In light of the recent implication of CRIPTO in fibrosis as described above, it is interesting to consider how different ECM substrates (these could include e.g., specific signaling domains and varying stiffness) may lead to different levels of CRIPTO expression induction in colon cancer cells [153,154]. This evidence concerns the gene CRIPTO and malignant colon neoplasm.